An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
Researchers discuss recent progress in targeting a so-called “undruggable” protein at American Association for Cancer Research meetings. In 1982,...
As 21,000 cancer researchers, clinicians, policymakers, and patient advocates thronged the Orange County Convention Center, Margaret Foti, PhD, MD...